Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis.
Journal: Headache
Published: August 12, 2021
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
Journal: Cephalalgia : an international journal of headache
Published: March 29, 2020
The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response.
Journal: Cephalalgia : an international journal of headache
Published: December 10, 2019
Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine.
Journal: Cephalalgia : an international journal of headache
Published: November 23, 2019
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study).
Journal: Cephalalgia : an international journal of headache
Published: August 22, 2019
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
Journal: Cephalalgia : an international journal of headache
Published: April 16, 2019
Sex and Gender Differences in Migraine-Evaluating Knowledge Gaps.
Journal: Journal of women's health (2002)
Published: August 22, 2018
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
Journal: Cephalalgia : an international journal of headache
Published: July 10, 2018
Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial.
Journal: Neurology
Published: March 23, 2018
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
Journal: Cephalalgia : an international journal of headache
Published: February 24, 2018
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
Journal: Cephalalgia : an international journal of headache
Published: October 13, 2017
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
Journal: The Lancet. Neurology
Published: December 28, 2016
Last Updated: 09/26/2026